- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
该股进入多头行情中，股价短线上涨概率较大。
- 中期趋势：
正处于反弹阶段。
- 长期趋势：
已有557家主力机构披露2025-12-31报告期持股数据，持仓量总计13.27亿股，占流通A股75.69%
- 波段诊断：
-
技术面诊股
诊断结果：5.0技术面打败了59%的股票
技术面评分前10的股票
近期的平均成本为27.74元。空头行情中，目前正处于反弹阶段，投资者可适当关注。
平均成本
近期的平均成本为27.74元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"27.74","date":1782633334,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，明显跑输行业平均水平。
[{"date":"2026.06.29","stock":"8.75","trade":"5.87","ind":"0.19"},{"date":"2026.06.26","stock":"-5.31","trade":"-4.86","ind":"-3.44"},{"date":"2026.06.25","stock":"-1.27","trade":"-1.35","ind":"1.82"},{"date":"2026.06.24","stock":"-2.32","trade":"-0.89","ind":"1.24"},{"date":"2026.06.23","stock":"0.49","trade":"3.68","ind":"-3.17"},{"date":"2026.06.22","stock":"1.55","trade":"0.07","ind":"2.13"},{"date":"2026.06.18","stock":"2.31","trade":"0.66","ind":"0.94"},{"date":"2026.06.17","stock":"-1.98","trade":"-1.16","ind":"1.31"},{"date":"2026.06.16","stock":"-2.55","trade":"-0.99","ind":"0.93"},{"date":"2026.06.15","stock":"-0.38","trade":"0.15","ind":"3.79"},{"date":"2026.06.12","stock":"-0.07","trade":"2.07","ind":"0.75"},{"date":"2026.06.11","stock":"1.78","trade":"-1.24","ind":"-0.68"},{"date":"2026.06.10","stock":"4.76","trade":"-0.14","ind":"-2.06"},{"date":"2026.06.09","stock":"0.76","trade":"0.45","ind":"3.02"},{"date":"2026.06.08","stock":"-2.57","trade":"-2.49","ind":"-3.22"},{"date":"2026.06.05","stock":"2.08","trade":"0.25","ind":"-2.21"},{"date":"2026.06.04","stock":"-1.35","trade":"-1.80","ind":"-0.27"},{"date":"2026.06.03","stock":"-2.69","trade":"-1.10","ind":"0.73"},{"date":"2026.06.02","stock":"-0.21","trade":"-2.06","ind":"1.63"},{"date":"2026.06.01","stock":"0.14","trade":"0.40","ind":"-1.51"},{"date":"2026.05.29","stock":"0.69","trade":"0.36","ind":"-1.81"}]
华东医药,深证成指,化学制药指数
压力支撑
该股压力位为26.82元，支撑位为25.04元。
[{"text":"\u538b\u529b\u4f4d","value":"26.82","date":1782662400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"25.04","date":1782662400,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前正处于反弹阶段，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.7资金面打败了29%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金总体呈流入状态，投资者可考虑关注该行业的个股。
更新时间：06月29日 17:28
| 机构今日流向(万元) | 4978.33 | 机构5日流向(万元) | 1260.11 |
| 机构10日流向(万元) | -464.17 | 机构20日流向(万元) | -6537.89 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量增加3583.53万股，其中基金净减仓151家，主力净减仓106家，暂未发现中长期投资价值。
截止2025-12-31，共557家主力机构（基金548家，券商集合理财3家，一般法人4家，社保基金1家，保险公司1家），持仓量总计132687.46万股，占流通A股75.69%
其中，基金持仓与2025-06-30相比：
增仓：102家 ，增持 1826.08万股
减仓：253家 ，减持 1815.44万股
新出现在主力名单中：167家 ，持有1454.54万股
从主力名单中消失：273家 ，原持有2761.9万股
其中，基金持仓与2025-06-30相比：
增仓：102家 ，增持 1826.08万股
减仓：253家 ，减持 1815.44万股
新出现在主力名单中：167家 ，持有1454.54万股
从主力名单中消失：273家 ，原持有2761.9万股
消息面诊股
诊断结果：5.7消息面打败了8%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 华东医药：6月26日获融资买入6765.10万元
2026-06-29 - 行业周报|化学制药指数跌-3.49%, 跑输上证指
2026-06-26 - 华东医药：6月25日获融资买入6759.02万元
2026-06-26 - 华东医药CDH17 ADC新药注射用HDM2017
2026-06-25 - 华东医药：注射用HDM2017临床试验获批
2026-06-25 - 华东医药“一日双响” 两大核心管线同步迎来突破
2026-06-25 - 华东医药：6月24日获融资买入8584.15万元
2026-06-25 - 华东医药：医美、ADC管线同步迎新突破
2026-06-24 - 华东医药三类医疗器械皮肤治疗仪V30获NMPA批准
2026-06-24 - 华东医药自研ADC创新药HDM2005新适应症IN
2026-06-24
消息列表
| 一般消息 | 重大事项 | 关联交易 | 2026-05-21 |
| 一般消息 | 股东大会 | 年度股东大会 | 2026-04-24 |
| 利好 | 分红转增 | 10派5.8元(含税) | 2026-04-24 |
| 一般消息 | 重大事项 | 关联交易 | 2026-04-24 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-03-20 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-03-07 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-12-31 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-11-11 |
| 一般消息 | 重大事项 | 关联交易 | 2025-09-23 |
| 利好 | 分红转增 | 10派3.5元(含税) | 2025-08-20 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-07-16 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 4条 | 0条 | 4条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：6.2行业面打败了95%的股票
化学制药行业最新资金流向
近10日来该行业走势不明显，跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑输大盘。
[{"date":"2026.06.29","price":"0.19","value":"5.87"},{"date":"2026.06.26","price":"-3.44","value":"-4.86"},{"date":"2026.06.25","price":"1.82","value":"-1.35"},{"date":"2026.06.24","price":"1.24","value":"-0.89"},{"date":"2026.06.23","price":"-3.17","value":"3.68"},{"date":"2026.06.22","price":"2.13","value":"0.07"},{"date":"2026.06.18","price":"0.94","value":"0.66"},{"date":"2026.06.17","price":"1.31","value":"-1.16"},{"date":"2026.06.16","price":"0.93","value":"-0.99"},{"date":"2026.06.15","price":"3.79","value":"0.15"},{"date":"2026.06.12","price":"0.75","value":"2.07"},{"date":"2026.06.11","price":"-0.68","value":"-1.24"},{"date":"2026.06.10","price":"-2.06","value":"-0.14"},{"date":"2026.06.09","price":"3.02","value":"0.45"},{"date":"2026.06.08","price":"-3.22","value":"-2.49"},{"date":"2026.06.05","price":"-2.21","value":"0.25"},{"date":"2026.06.04","price":"-0.27","value":"-1.80"},{"date":"2026.06.03","price":"0.73","value":"-1.10"},{"date":"2026.06.02","price":"1.63","value":"-2.06"},{"date":"2026.06.01","price":"-1.51","value":"0.40"},{"date":"2026.05.29","price":"-1.81","value":"0.36"}]
深证成指,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 花园生物 | 64.13% | 1.11% | 5.8分 |
| 2 | 富祥股份 | 39.74% | 3.48% | 6.2分 |
| 3 | 灵康药业 | 32.52% | 8.12% | 6.4分 |
| 4 | - | 27.19% | 40.42% | 分 |
| 5 | 百利天恒 | 24.50% | 30.57% | 5.9分 |
| 6 | 贝达药业 | 22.67% | 10.06% | 6.6分 |
| 8 | 艾力斯 | 20.07% | 25.16% | 6.9分 |
| 10 | 赛分科技 | 17.05% | 12.19% | 6.4分 |
| 12 | 泽璟制药 | 14.49% | 29.67% | 6.6分 |
| 14 | 海南海药 | 10.46% | 22.37% | 5.4分 |
| 16 | 前沿生物 | 10.00% | 20.75% | 6.3分 |
| 18 | 海欣股份 | 8.82% | 0.45% | 5.6分 |
| 20 | 司太立 | 8.36% | 17.10% | 5.7分 |
| 22 | 科源制药 | 7.85% | -11.46% | 4.2分 |
| 24 | - | 7.27% | 8.58% | 分 |
| 26 | 键凯科技 | 5.06% | 15.36% | 6.1分 |
| 28 | 吉贝尔 | 3.78% | 5.56% | 5.7分 |
| 30 | 石药创新 | 3.51% | 14.46% | 5.6分 |
| 32 | 海正药业 | 2.99% | 6.71% | 6.0分 |
| 34 | - | 2.39% | 6.94% | 分 |
| 36 | 新华制药 | 1.57% | 11.21% | 5.4分 |
| 38 | 泰恩康 | 1.33% | 10.18% | 5.7分 |
| 40 | 千红制药 | 0.79% | 10.38% | 6.0分 |
| 42 | 共同药业 | 0.36% | 1.55% | 5.2分 |
| 44 | 中关村 | 0.00% | 0.00% | 5.2分 |
| 46 | 东诚药业 | -0.39% | 1.43% | 5.7分 |
| 48 | 威尔药业 | -0.76% | 0.57% | 4.5分 |
| 50 | 信立泰 | -1.56% | 6.89% | 5.7分 |
| 52 | 华北制药 | -2.22% | 1.61% | 5.0分 |
| 54 | 金城医药 | -2.28% | -0.47% | 5.8分 |
| 56 | 力生制药 | -2.62% | 2.41% | 5.4分 |
| 58 | 民生健康 | -2.99% | -0.56% | 4.9分 |
| 60 | 京新药业 | -3.51% | 5.78% | 5.7分 |
| 62 | 海翔药业 | -3.62% | 2.70% | 5.0分 |
| 64 | 辰欣药业 | -3.84% | 0.99% | 4.8分 |
| 66 | 金陵药业 | -4.17% | -0.66% | 5.1分 |
| 68 | 翰宇药业 | -4.37% | -1.82% | 5.2分 |
| 70 | 东北制药 | -4.56% | 1.15% | 5.0分 |
| 72 | 凯因科技 | -4.71% | 1.91% | 4.4分 |
| 74 | - | -5.04% | -1.17% | 分 |
| 76 | - | -5.20% | 6.54% | 分 |
| 78 | ST惠程 | -5.59% | -3.79% | 4.0分 |
| 80 | 鲁抗医药 | -5.84% | 4.21% | 6.2分 |
| 82 | 广生堂 | -5.92% | 21.38% | 5.3分 |
| 84 | 盟科药业 | -6.41% | -2.01% | 4.3分 |
| 86 | ST诺泰 | -6.48% | 3.14% | 5.0分 |
| 88 | 奥赛康 | -6.58% | 7.49% | 6.0分 |
| 90 | 福元医药 | -6.65% | 2.52% | 5.2分 |
| 92 | ST能特 | -6.90% | -2.70% | 4.7分 |
| 94 | 北大医药 | -7.06% | -3.29% | 4.1分 |
| 96 | 德展健康 | -7.42% | 7.59% | 4.7分 |
| 98 | 首药控股 | -7.44% | 6.92% | 5.5分 |
| 100 | - | -7.53% | 3.80% | 分 |
| 102 | 卫信康 | -7.96% | -0.83% | 4.7分 |
| 104 | - | -8.60% | -7.78% | 分 |
| 106 | 海森药业 | -8.79% | -5.79% | 3.6分 |
| 108 | 华仁药业 | -8.93% | -1.54% | 5.1分 |
| 110 | 健友股份 | -9.02% | 2.54% | 5.0分 |
| 112 | 福安药业 | -9.42% | -1.14% | 5.0分 |
| 114 | 舒泰神 | -9.70% | 14.57% | 5.8分 |
| 116 | 誉衡药业 | -9.80% | 3.09% | 5.6分 |
| 118 | 润都股份 | -10.12% | -2.12% | 4.9分 |
| 120 | 亚太药业 | -10.20% | 9.15% | 5.0分 |
| 122 | 溢多利 | -10.89% | -4.02% | 5.0分 |
| 124 | 尔康制药 | -11.14% | -3.46% | 4.6分 |
| 126 | 赛托生物 | -11.21% | -1.47% | 4.9分 |
| 128 | 海创药业 | -11.80% | 1.18% | 5.0分 |
| 130 | 上海谊众 | -12.56% | 0.49% | 4.5分 |
| 132 | 本立科技 | -13.25% | -5.52% | 4.0分 |
| 134 | 向日葵 | -13.51% | -5.26% | 3.5分 |
| 136 | 拓新药业 | -13.79% | -3.18% | 4.2分 |
| 138 | 奥翔药业 | -15.04% | 1.64% | 4.3分 |
| 140 | 联环药业 | -16.21% | -5.46% | 4.8分 |
| 142 | 莎普爱思 | -16.26% | -5.47% | 4.4分 |
| 144 | 宏源药业 | -17.24% | -10.47% | 4.4分 |
| 146 | 冀衡医药 | -19.71% | -6.11% | 4.1分 |
| 148 | 多瑞医药 | -21.84% | -10.77% | 3.8分 |
| 150 | 仟源医药 | -23.35% | -5.98% | 4.8分 |
| 152 | 美诺华 | -24.00% | -8.10% | 4.1分 |
| 154 | 悦康药业 | -26.99% | -0.54% | 4.5分 |
| 156 | ST南新 | -29.94% | -0.66% | 4.8分 |
| 158 | 常山药业 | -40.82% | -7.75% | 4.9分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2026-03-31 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 22/218 ， 104/218。
[{"date":"2026-03-31","value":"3.97","vol":"0.43"},{"date":"2025-12-31","value":"14.26","vol":"-2.03"},{"date":"2025-09-30","value":"11.65","vol":"1.53"},{"date":"2025-06-30","value":"7.75","vol":"1.24"},{"date":"2025-03-31","value":"3.88","vol":"-0.13"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
3.97 | 14.26 | 11.65 | 7.75 | 3.88 |
| 行业(%) | 0.43 | -2.03 | 1.53 | 1.24 | -0.13 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"33.94","vol":"50.72"},{"date":"2025-12-31","value":"32.36","vol":"49.72"},{"date":"2025-09-30","value":"33.52","vol":"49.60"},{"date":"2025-06-30","value":"33.90","vol":"49.57"},{"date":"2025-03-31","value":"32.87","vol":"49.06"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
33.94 | 32.36 | 33.52 | 33.90 | 32.87 |
| 行业(%) | 50.72 | 49.72 | 49.60 | 49.57 | 49.06 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 63/218 ， 61/218。
[{"date":"2026-03-31","value":"4.17","vol":"25.51"},{"date":"2025-12-31","value":"4.07","vol":"38.97"},{"date":"2025-09-30","value":"3.77","vol":"141.63"},{"date":"2025-06-30","value":"3.39","vol":"78.56"},{"date":"2025-03-31","value":"3.12","vol":"0.01"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
4.17 | 4.07 | 3.77 | 3.39 | 3.12 |
| 行业(%) | 25.51 | 38.97 | 141.63 | 78.56 | 0.01 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"9.56","vol":"47.13"},{"date":"2025-12-31","value":"-2.78","vol":"-26.11"},{"date":"2025-09-30","value":"7.24","vol":"-2.93"},{"date":"2025-06-30","value":"7.00","vol":"59.61"},{"date":"2025-03-31","value":"6.06","vol":"-10.40"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
9.56 | -2.78 | 7.24 | 7.00 | 6.06 |
| 行业(%) | 47.13 | -26.11 | -2.93 | 59.61 | -10.40 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 2/218 ， 12/218。
[{"date":"2026-03-31","value":"0.28","vol":"0.10"},{"date":"2025-12-31","value":"1.13","vol":"0.41"},{"date":"2025-09-30","value":"0.84","vol":"0.31"},{"date":"2025-06-30","value":"0.57","vol":"0.21"},{"date":"2025-03-31","value":"0.28","vol":"0.10"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.28 | 1.13 | 0.84 | 0.57 | 0.28 |
| 行业(次) | 0.10 | 0.41 | 0.31 | 0.21 | 0.10 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"1.36","vol":"0.65"},{"date":"2025-12-31","value":"5.72","vol":"2.58"},{"date":"2025-09-30","value":"4.35","vol":"1.93"},{"date":"2025-06-30","value":"2.92","vol":"1.29"},{"date":"2025-03-31","value":"1.48","vol":"0.66"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
1.36 | 5.72 | 4.35 | 2.92 | 1.48 |
| 行业(次) | 0.65 | 2.58 | 1.93 | 1.29 | 0.66 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2026-03-31","value":"-7.62","vol":"-2.81"},{"date":"2025-12-31","value":"14.93","vol":"16.49"},{"date":"2025-09-30","value":"1.40","vol":"4.26"},{"date":"2025-06-30","value":"30.07","vol":"2.95"},{"date":"2025-03-31","value":"-7.76","vol":"-26.33"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | -7.62 | 14.93 | 1.40 | 30.07 | -7.76 |
| 行业 | -2.81 | 16.49 | 4.26 | 2.95 | -26.33 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"1.51","vol":"1.60"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"1.53","vol":"1.71"},{"date":"2025-03-31","value":"","vol":"0.00"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 1.51 | - | 1.53 | - |
| 行业 | 0.00 | 1.60 | 0.00 | 1.71 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 31/218 ， 20/218。
[{"date":"2026-03-31","value":"1.67","vol":"3.57"},{"date":"2025-12-31","value":"1.62","vol":"3.31"},{"date":"2025-09-30","value":"1.56","vol":"3.48"},{"date":"2025-06-30","value":"1.56","vol":"3.66"},{"date":"2025-03-31","value":"1.56","vol":"3.57"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
1.67 | 1.62 | 1.56 | 1.56 | 1.56 |
| 行业 | 3.57 | 3.31 | 3.48 | 3.66 | 3.57 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"1.21","vol":"2.93"},{"date":"2025-12-31","value":"1.14","vol":"2.69"},{"date":"2025-09-30","value":"1.16","vol":"2.73"},{"date":"2025-06-30","value":"1.16","vol":"2.88"},{"date":"2025-03-31","value":"1.17","vol":"2.80"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
1.21 | 1.14 | 1.16 | 1.16 | 1.17 |
| 行业 | 2.93 | 2.69 | 2.73 | 2.88 | 2.80 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 54/218 ， 68/218。
[{"date":"2026-03-31","value":"34.63","vol":"33.54"},{"date":"2025-12-31","value":"35.52","vol":"34.70"},{"date":"2025-09-30","value":"38.65","vol":"34.06"},{"date":"2025-06-30","value":"37.87","vol":"34.12"},{"date":"2025-03-31","value":"37.73","vol":"34.09"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
34.63 | 35.52 | 38.65 | 37.87 | 37.73 |
| 行业(%) | 33.54 | 34.70 | 34.06 | 34.12 | 34.09 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.54","vol":"9.77"},{"date":"2025-12-31","value":"0.56","vol":"1.76"},{"date":"2025-09-30","value":"0.64","vol":"1.19"},{"date":"2025-06-30","value":"0.62","vol":"0.87"},{"date":"2025-03-31","value":"0.62","vol":"1.44"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.54 | 0.56 | 0.64 | 0.62 | 0.62 |
| 行业(%) | 9.77 | 1.76 | 1.19 | 0.87 | 1.44 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2026-05-14 | 买入 | |
| 长城国瑞证券 | 2026-05-14 | 买入 | |
| 国泰海通证券 | 2026-05-12 | 买入 | |
| 东北证券 | 2026-05-07 | 增持 | |
| 东吴证券 | 2026-04-30 | 买入 | |
| 华泰证券 | 2026-04-27 | 买入 | 买入 |
机构预测
机构预测该股2026年每股收益与前一年相同，长期投资价值一般。
[{"date":"2022","yellowRectValue":"24.99","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"28.39","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"35.12","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"34.14","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"38.26","blueLineValue":"2.18","type":"YC"}]